Genedrive Plc - Company Profile

Powered by

All the data and insights you need on Genedrive Plc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Genedrive Plc Strategy Report

  • Understand Genedrive Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Genedrive Plc: Overview

Select Item

Related keylists

Genedrive Plc (Genedrive) formerly Epistem Holdings Plc specializes in the development of point-of-care molecular diagnostic platforms. The company's major activities include the creation of innovative tests for various clinical indications such as genotyping, pathogen detection, and infectious disease detection. The company's major products include the Genedrive MT-RNR1 ID kit, used for detecting antibiotic-induced hearing loss in neonates, and the Genedrive CYP2C19 ID kit, a rapid point-of-care test for CYP2C19 genotyping. The company's products are primarily used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. The company provides its products in North America, Asia Pacific, Europe, Middle East and Africa (EMEA) region through its distribution partners. Genedrive is headquartered in Manchester, the UK.

 Gain a 360-degree view of Genedrive Plc and make more informed decisions for your business Gain a 360-degree view of Genedrive Plc and make more informed decisions for your business Find out more
Headquarters United Kingdom
Address 48 Grafton Street, Manchester, England, M139XX
Website www.genedriveplc.com
Telephone 44 161 9890245
No of Employees 43
Industry Medical Equipment
Ticker Symbol & Exchange GDR (LON)
Revenue (2023) $74,600 12.2% (2023 vs 2022)
EPS XYZ
Net Income (2023) XYZ -10.2% (2023 vs 2022)
Market Cap* $10.9M
Net Profit Margin (2023) XYZ 1.9% (2023 vs 2022)
* As of and is in US$
View Genedrive Plc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Genedrive Plc premium industry data and analytics

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

10+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

Products and Services

Products Brands
Genedrive HCV ID Kit Genedrive
Genedrive 96 SARS-CoV-2 Kit
Genedrive MT-RNR1 ID Kit
XYZ
XYZ
XYZ
Understand Genedrive Plc portfolio and identify potential areas for collaboration Understand Genedrive Plc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Genedrive Plc GSK plc GenMark Diagnostics Inc Immunodiagnostic Systems Holdings Ltd Tiziana Life Sciences Plc
Headquarters United Kingdom United Kingdom United States of America United Kingdom United Kingdom
City Manchester Brentford Carlsbad Tyne and Wear Hamilton
State/Province England England California Tyne and Wear South Lanarkshire
No. of Employees 43 69,400 - 16 9
Entity Type Public Public Private Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
James Bernard Cheek Director; Chief Executive Officer Executive Board 2023 57
Russell Shaw Chief Financial Officer; Director Executive Board 2022 45
Gino Miele Chief Scientific Officer Senior Management 2023 54
Ian Gilham, Ph.D. Chairman Non Executive Board 2015 64
Chris Yates Director Non Executive Board 2018 50
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Genedrive Plc key executives to enhance your sales strategy Gain insight into Genedrive Plc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward